Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease

Poster session.

Presentations:

• 9:00 AM – 11:00 AM ET

  Management of Rheumatic Diseases During COVID-19: A National Veterans Affairs Survey of Rheumatologists
  Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
• 9:00 AM – 11:00 AM ET

  Hydroxychloroquine and Chloroquine and Hospitalizations for Viral Infection in the Pre-COVID-19 Era
  Sasha Bernatsky, MD, PhD – McGill University
• 9:00 AM – 11:00 AM ET

  Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations
  Quinn Pritchett – University of Utah
• 9:00 AM – 11:00 AM ET

  The Impact of the COVID-19 Pandemic on Patients with Chronic Rheumatic Diseases: A Study in 15 Arab Countries
  Nelly Ziade, MD, PhD – Saint-Joseph University
• 9:00 AM – 11:00 AM ET

  Geographical Variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists
  Bella Mehta, MS, MBBS – Hospital for Special Surgery, Weill Cornell Medicine
• 9:00 AM – 11:00 AM ET

  Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
  Milena A. Gianfrancesco, PhD, MPH – University of California, San Francisco
• 9:00 AM – 11:00 AM ET

  Antimalarial Drug Shortages During the COVID-19 Pandemic: Results from the Global Rheumatology Alliance Patient Experience Survey
  Emily Sirotich, BSc – McMaster University
• 9:00 AM – 11:00 AM ET

  COVID-19 Infection Among Patients with Rheumatic Disease on Biologic & Targeted Therapies: A Systematic Review
  Akhil Sood, MD – University of Texas Medical Branch
• 9:00 AM – 11:00 AM ET

  Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases
  Zakaria El Ouali, MD – University Hospital of Ibn Rochd
• 9:00 AM – 11:00 AM ET

  Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned
  Dominique Kinnett-Hopkins, PhD – Northwestern University Feinberg School of Medicine
• 9:00 AM – 11:00 AM ET

  Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis
  Michael Putman, MD, MSc – The Medical College of Wisconsin
• 9:00 AM – 11:00 AM ET

  Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
  Georg Schett, MD – Universitaetsklinikum Erlangen
• 9:00 AM – 11:00 AM ET

  Experiences of Patients with Rheumatic Diseases in the US During the Early Months of the COVID-19 Pandemic
  Kaleb Michaud, PhD – University of Nebraska Medical Center
• 9:00 AM – 11:00 AM ET

  Colchicine to Weather the Storm in Hospitalized Patients with COVID-19
  Luigi Brunetti, PharmD – Rutgers Ernest Mario School of Pharmacy
• 9:00 AM – 11:00 AM ET

  Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19?
  Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Ramón y Cajal
• 9:00 AM – 11:00 AM ET

  COVID -19 Lung Inflammation – What Have We Learnt so Far ?
  Sriya Gokaraju – Southend University Hospital NHS Trust
• 9:00 AM – 11:00 AM ET

  Differential Characteristics in Inflammatory Rheumatologic Patients with Severe and Mild COVID-19 Infection
  Paula García Escudero, MD – Hospital Universitario Cruces
• 9:00 AM – 11:00 AM ET

  Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications
  Daniel Watrous, MD – Sierra Pacific Arthritis & Rheumatology Centers
• 9:00 AM – 11:00 AM ET

  PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
  Gregory J. Vitone, BS – Hospital for Special Surgery
• 9:00 AM – 11:00 AM ET

  Lasting COVID-19 Impacts on US Rheumatology Practices
  Phil Pouliot, BA, -None- – spherix global insights
• 9:00 AM – 11:00 AM ET

  Characteristics of Rheumatology Outpatients with Suspected or Confirmed COVID-19 During the Pandemic in New York City
  Medha Barbhaiya, MD, MPH – Hospital for Special Surgery